Presentation is loading. Please wait.

Presentation is loading. Please wait.

Quinidine for Brugada syndrome: Panacea or poison?

Published byHedvig Justesen Modified over 5 years ago

Similar presentations

Presentation on theme: "Quinidine for Brugada syndrome: Panacea or poison?"— Presentation transcript:

1 Quinidine for Brugada syndrome: Panacea or poison?
Jo-Jo Hai, MBBS, Chun-Ka Wong, MBBS, Pak-Hei Chan, MBBS, Hung-Fat Tse, MD, PhD, Tak-Cheung Yung, MBBS, Chung-Wah Siu, MD  HeartRhythm Case Reports  Volume 2, Issue 6, Pages (November 2016) DOI: /j.hrcr Copyright © 2016 Heart Rhythm Society Terms and Conditions

2 Figure 1 A: Standard 12-lead electrocardiogram (ECG) showing partial right bundle branch block with a coved ST-segment elevation and negative T-wave deflections in leads V1 and V2, compatible with type I Brugada pattern; the corrected QT (QTc) interval was 493 msec. B: The stored ECGs showed an episode of ventricular fibrillation/tachycardia, triggering an implantable cardioverter-defibrillator shock. C: Standard 12-lead ECG showing frequent premature ventricular complexes of right ventricular outflow tract origin. D: In-hospital telemetry recording showing an episode of torsades de pointes initiated by a long–short sequence of ventricular bigeminy (asterisk). HeartRhythm Case Reports 2016 2, DOI: ( /j.hrcr ) Copyright © 2016 Heart Rhythm Society Terms and Conditions

3 Figure 2 The sequence chromatogram of the 2 mutations: R1192Q (A) and E1784K (B) in SCN5A, the gene encoding Nav1.5, the α-subunit of the cardiac sodium channel. C: Schematic representation of the primary structure of α-subunit of the cardiac sodium channel with locations of 2 SCN5A mutations. HeartRhythm Case Reports 2016 2, DOI: ( /j.hrcr ) Copyright © 2016 Heart Rhythm Society Terms and Conditions

4 Figure 3 A: The effects of mexiletine (150 mg) on the corrected QT interval during atrial paced rate of 70 beats per minute. B: Premature ventricular complexes ablated sequentially at the anterior right ventricular outflow tract, subpulmonary valvular region, and anterior right ventricular wall. Purkinje potentials were seen at the final ablation site. HeartRhythm Case Reports 2016 2, DOI: ( /j.hrcr ) Copyright © 2016 Heart Rhythm Society Terms and Conditions

Download ppt "Quinidine for Brugada syndrome: Panacea or poison?"

Similar presentations

A novel de novo calmodulin mutation in a 6-year-old boy who experienced an aborted cardiac arrest  Kazuhiro Takahashi, MD, PhD, Taisuke Ishikawa, DVM,

A novel de novo calmodulin mutation in a 6-year-old boy who experienced an aborted cardiac arrest  Kazuhiro Takahashi, MD, PhD, Taisuke Ishikawa, DVM,
Molecular and Cellular Mechanisms of Cardiac Arrhythmias

Molecular and Cellular Mechanisms of Cardiac Arrhythmias
Wolff-Parkinson-White syndrome due to a left atrial appendage–to–left ventricular connection: A case of a successful pathway elimination from inside of.

Wolff-Parkinson-White syndrome due to a left atrial appendage–to–left ventricular connection: A case of a successful pathway elimination from inside of.
Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome  Yasuaki.

Appearance of J wave in the inferolateral leads and ventricular fibrillation provoked by mild hypothermia in a patient with Brugada syndrome  Yasuaki.
Isolated left bundle branch block progressing to complete heart block and asystole: A novel presentation of a desmin mutation  Addison S. Gearhart, MD,

Isolated left bundle branch block progressing to complete heart block and asystole: A novel presentation of a desmin mutation  Addison S. Gearhart, MD,
A novel de novo calmodulin mutation in a 6-year-old boy who experienced an aborted cardiac arrest  Kazuhiro Takahashi, MD, PhD, Taisuke Ishikawa, DVM,

A novel de novo calmodulin mutation in a 6-year-old boy who experienced an aborted cardiac arrest  Kazuhiro Takahashi, MD, PhD, Taisuke Ishikawa, DVM,
A subtype of idiopathic ventricular fibrillation and its relevance to catheter ablation and genetic variants  Takahiko Nishiyama, MD, Yoshiyasu Aizawa,

A subtype of idiopathic ventricular fibrillation and its relevance to catheter ablation and genetic variants  Takahiko Nishiyama, MD, Yoshiyasu Aizawa,
Swimming pool saline chlorination units and implantable cardiac devices: A source for potentially fatal electromagnetic interference  John Wight, BS,

Swimming pool saline chlorination units and implantable cardiac devices: A source for potentially fatal electromagnetic interference  John Wight, BS,
A case of paroxysmal atrioventricular block–induced cardiac arrest

A case of paroxysmal atrioventricular block–induced cardiac arrest
Challenges in the diagnosis and management of idiopathic ventricular fibrillation  Jonathan Lipton, MD, PhD, George J. Klein, MD, Raymond W. Sy, MBBS,

Challenges in the diagnosis and management of idiopathic ventricular fibrillation  Jonathan Lipton, MD, PhD, George J. Klein, MD, Raymond W. Sy, MBBS,
Is it bradycardia or something else causing symptoms?

Is it bradycardia or something else causing symptoms?
Quinidine effective for the management of ventricular and atrial arrhythmias associated with Brugada syndrome  Laura Halperin, BSc, Greg Mellor, MD, Mario.

Quinidine effective for the management of ventricular and atrial arrhythmias associated with Brugada syndrome  Laura Halperin, BSc, Greg Mellor, MD, Mario.
Novel CALM3 mutations in pediatric long QT syndrome patients support a CALM3- specific calmodulinopathy  Marie-A. Chaix, MD, MSc, Tamara T. Koopmann, PhD,

Novel CALM3 mutations in pediatric long QT syndrome patients support a CALM3- specific calmodulinopathy  Marie-A. Chaix, MD, MSc, Tamara T. Koopmann, PhD,
Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child  Carlo de Asmundis, MD, PhD,

Concomitant Brugada syndrome substrate ablation and epicardial abdominal cardioverter-defibrillator implantation in a child  Carlo de Asmundis, MD, PhD,
Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome  Maria J. Farag, BS, Joseph.

Use of topical lidocaine in eliminating mechanically stimulated ventricular fibrillation in a patient with short QT syndrome  Maria J. Farag, BS, Joseph.
HeartRhythm Case Reports

HeartRhythm Case Reports
HeartRhythm Case Reports

HeartRhythm Case Reports
Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient  Isla McClelland, MD,

Respiratory rate trending as a cause for atrial lead noise: A first report in an implantable cardioverter-defibrillator patient  Isla McClelland, MD,
Irregular wide QRS complex tachycardia in a patient with pulmonary hypertension: What is the mechanism?  Abigail Louise D. Te, MD, Fa-Po Chung, MD, Yenn-Jiang.

Irregular wide QRS complex tachycardia in a patient with pulmonary hypertension: What is the mechanism?  Abigail Louise D. Te, MD, Fa-Po Chung, MD, Yenn-Jiang.
Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome  Akira Miyake, MD, Heima.

Successful prenatal management of ventricular tachycardia and second-degree atrioventricular block in fetal long QT syndrome  Akira Miyake, MD, Heima.

Similar presentations

Ads by Google